The Evidence Base
Post
Public reactions to the revised Medicare drug pricing provisions in the Inflation Reduction Act
Since the Centers for Medicare & Medicaid Services (CMS) announced that it has ...
Register with The Evidence Base for free to access this content
Already have an account? Sign in
By registering with The Evidence Base, you will receive our weekly round-up and other relevant editorial content. You can opt-out at any time. View our privacy policy here.